YANG, J.; ZHAO, M.; ZHOU, X.; YAN, M.; ZHAO, X.; LI, F. Cost-Effectiveness of Sorafenib, Lenvatinib, and FOLFOX4 for Advanced Hepatocellular Carcinoma in China. Journal of Health Science and Medical Research, [S. l.], v. 43, n. 4, p. e20251153, 2025. DOI: 10.31584/jhsmr.20251153. Disponível em: https://he01.tci-thaijo.org/index.php/jhsmr/article/view/280260. Acesso em: 1 oct. 2026.